WKL Wolters Kluwer NV

The Healthcare Technology Report Names Dr. Denise Basow of Wolters Kluwer to Top 25 Women Leaders in Healthcare Software

, a leading global provider of trusted clinical technology and evidence-based solutions, today announced that Denise Basow, MD, CEO for Clinical Effectiveness, has been ranked among the , an award given by The Healthcare Technology Report.

According to , the Top 25 honor recognizes “women leaders who exemplify achievement in a hyper-competitive industry that seeks to have profound impact across national and global communities. The importance of their leadership roles is paramount particularly as healthcare providers increasingly rely on data and technology to improve the way care is delivered. By dedicating themselves to their chosen field, through decades of expanding expertise and capabilities, these are the women leaders most respected and admired in healthcare software.”

“It is an honor to receive this award and I share this recognition with all the women leaders in our organization,” said Dr. Basow. “In these challenging times, we redouble our commitment to the hard-working doctors, nurses, pharmacists and the many clinicians on the front lines of the COVID-19 pandemic to ensure they have the best available evidence to care for their patients.”

As President and CEO for Clinical Effectiveness at Wolters Kluwer, Health, Dr. Basow leads a global organization helping hospitals and health systems improve care with acclaimed expert solutions including ®, ®, ® and ®. Previously, Dr. Basow served as Vice President and General Manager, Clinical Decision Support. As a primary care physician who joined UpToDate in 1996, Dr. Basow has also held the positions of Deputy Editor, Executive Editor and Editor-in-Chief.

Dr. Basow is board-certified in Internal Medicine. She received a BA in Chemistry from Duke University, attended Baylor College of Medicine and completed her internal medicine residency at Johns Hopkins.

To learn more about the awards, please visit:

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit and follow us on and Twitter .

For more information, visit , follow us on , , , and .

EN
08/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wolters Kluwer NV

 PRESS RELEASE

Share Buyback Transaction Details December 11 – December 17, 2025

Share Buyback Transaction Details December 11 – December 17, 2025 PRESS RELEASE                                         Share Buyback Transaction Details December 11 – December 17, 2025 Alphen aan den Rijn – December 18, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 238,453 of its own ordinary shares in the period from December 11, 2025, up to and including December 17, 2025, for €21.4 million and at an average share price of €89.85. These repurchases are part of the share buyback...

 PRESS RELEASE

Share Buyback Transaction Details December 4 – December 10, 2025

Share Buyback Transaction Details December 4 – December 10, 2025 PRESS RELEASE                                         Share Buyback Transaction Details December 4 – December 10, 2025 Alphen aan den Rijn – December 11, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 209,603 of its own ordinary shares in the period from December 4, 2025, up to and including December 10, 2025, for €18.7 million and at an average share price of €89.33. These repurchases are part of the share buyback pr...

David Vagman ... (+5)
  • David Vagman
  • CFA
  • Marc Hesselink
  • CFA
  • Thymen Rundberg

Wolters Kluwer/AI winner at an attractive valuation/BUY

Our conviction in the Wolters Kluwer investment case remains high. Three positives stand out in our view. Firstly, current trading is solid, with 9M25 organic revenue growth beating expectations. Secondly, the company's expert curated (proprietary) content is a strong moat vs AI-only alternatives as the company operates in high-stake environments where reliability is key. Thirdly, valuation has become highly attractive. We slightly lower our target price to €160 per share (from €173). We keep ou...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch